About F-box/LRR-repeat protein 20
F-box/LRR-repeat protein 20 (FBXL20) is a protein
from Homo sapiens identified by UniProt accession
Q96IG2, 436 residues long.
MolForge cross-references it against 0 known binders and
118 disease associations.
Target properties
| Protein name | F-box/LRR-repeat protein 20 |
| UniProt accession | Q96IG2 |
| Gene | FBXL20 |
| Organism | Homo sapiens |
| Length | 436 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (118)
Diseases linked to this target (Open Targets).
- creatinine measurement · score 0.24
- blood phosphate measurement · score 0.23
- Red cell distribution width · score 0.23
- mean corpuscular volume · score 0.22
- mean platelet volume · score 0.22
- vital capacity · score 0.22
- platelet count · score 0.20
- mean corpuscular hemoglobin concentration · score 0.19
- serum urea measurement · score 0.19
- Immature Reticulocyte Fraction Measurement · score 0.17
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96IG2-F1 | alphafold | PREDICTED | 90.87 | — |
Amino-acid sequence (436 residues)
MRRDVNGVTK SRFEMFSNSD EAVINKKLPK ELLLRIFSFL DVVTLCRCAQ VSRAWNVLAL DGSNWQRIDL FDFQRDIEGR VVENISKRCG GFLRKLSLRG CLGVGDNALR TFAQNCRNIE VLNLNGCTKT TDATCTSLSK FCSKLRHLDL ASCTSITNMS LKALSEGCPL LEQLNISWCD QVTKDGIQAL VRGCGGLKAL FLKGCTQLED EALKYIGAHC PELVTLNLQT CLQITDEGLI TICRGCHKLQ SLCASGCSNI TDAILNALGQ NCPRLRILEV ARCSQLTDVG FTTLARNCHE LEKMDLEECV QITDSTLIQL SIHCPRLQVL SLSHCELITD DGIRHLGNGA CAHDQLEVIE LDNCPLITDA SLEHLKSCHS LERIELYDCQ QITRAGIKRL RTHLPNIKVH AYFAPVTPPP SVGGSRQRFC RCCIIL
Explore F-box/LRR-repeat protein 20 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets